Polymyalgia rheumatica (PMR) is the second most common inflammatory rheumatic disease
after rheumatoid arthritis in persons older than 50 years, 1 reaching an estimated …

Objective. To identify the features of PMR that may predict the duration of steroid therapy, the
occurrence of relapses and the late development of GCA. Methods. Prospective cohort study …

The British and European recommendations for managing PMR recommend specialist
referral in the presence of atypical clinical features and failure to respond to glucocorticoids …

Objectives To assess clinical features in patients with polymyalgia rheumatica (PMR) in
Japan by the International Classification of Disease (ICD)-10 code assignment. Methods …

Polymyalgia rheumatica (PMR) is an inflammatory disease characterized by bilateral pain
involving predominantly the shoulders and proximal aspects of the arms and less commonly …

Objective. The duration of treatment with glucocorticoids (GC) in polymyalgia rheumatica
(PMR) is often longterm. Amino bisphosphonates (N-BP) are used in PMR for the prevention …

Objectives To compare clinical characteristics, imaging findings and treatment requirements
of patients with immune checkpoint inhibitor-mediated polymyalgia rheumatica (ICI-PMR) …

Background Polymyalgia rheumatica (PMR) is an inflammatory disorder of the elderly
characterized by girdle pain and stiffness, constitutional symptoms and elevation of …

Objectives To evaluate the efficacy of a fast track clinic (FTC) for patients suspected of
polymyalgia rheumatica (PMR) regarding symptom duration, prednisolone initiation before …

Polymyalgia rheumatica (PMR) occurs almost exclusively in persons aged 50 years or older
and it is the second most common inflammatory rheumatic disease in older people after …